Skip to main content
OpenTrials

Clinical trial condition

Blood Coagulation Disorders, Inherited

Explore clinical trials studying Blood Coagulation Disorders, Inherited. Study availability and eligibility vary by location and protocol.

852 public trials 115 recruiting studies
Refine in advanced search Browse all conditions

Blood Coagulation Disorders, Inherited trial results

Completed

PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Hemophilia A

NCT02492984

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • The Affiliated Hospital of Guizhou Medical University Guiyang, Guizhou, China
  • Henan Provincial People's Hospital Zhengzhou, Henan, China
  • Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China
  • Department of Hematology,The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
View all 15 locations
View Trial Details
Completed

Safety and Efficacy of Turoctocog Alfa in Previously Treated Male Children With Haemophilia A

NCT01138501

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Novo Nordisk Investigational Site Phoenix, Arizona, United States
  • Novo Nordisk Investigational Site Orange, California, United States
  • Novo Nordisk Investigational Site Torrance, California, United States
  • Novo Nordisk Investigational Site Tampa, Florida, United States
View all 38 locations
View Trial Details
Completed

Safety and Efficacy of Turoctocog Alfa in Haemophilia A Subjects

NCT00840086

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Novo Nordisk Investigational Site Little Rock, Arkansas, United States
  • Novo Nordisk Investigational Site Long Beach, California, United States
  • Novo Nordisk Investigational Site Tampa, Florida, United States
  • Novo Nordisk Investigational Site Atlanta, Georgia, United States
View all 63 locations
View Trial Details
Completed

Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds

NCT00486278

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
Locations
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Augusta, Georgia, United States
  • Novo Nordisk Investigational Site Chicago, Illinois, United States
  • Novo Nordisk Investigational Site Indianapolis, Indiana, United States
View all 45 locations
View Trial Details
Completed

Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A Subjects

NCT00837356

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Novo Nordisk Investigational Site Berlin, Germany
  • Novo Nordisk Investigational Site Hanover, Germany
  • Novo Nordisk Investigational Site Tel Litwinsky, Israel
  • Novo Nordisk Investigational Site Florence, Italy
View Trial Details
Completed

Study Evaluating Safety And Efficacy Of Moroctocog Alfa (AF-CC) In Previously Treated Hemophilia A Patients

NCT00914459

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Kuopio University Hospital Kuopio, Finland
  • LTD Medinvesti- Institute of hematology and transfusiology Tbilisi, Georgia
  • Centro di Riferimento Regionale per la cura dell'Emofilia e delle Malattie Emorragiche Congenite Parma, Italy
  • Spitalul Clinic Judetean de Urgenta Craiova Craiova, Dolj, Romania
View all 17 locations
View Trial Details

Related conditions